Linderstrøm-Lang and the Carlsberg Laboratory: the view of a postdoctoral fellow in 1954.

Por Richards, F. M.
Publicado em 1992

Differences in hydrogen exchange behavior between the oxidized and reduced forms of Escherichia coli thioredoxin.

Por Kaminsky, S. M., Richards, F. M.
Publicado em 1992

Reduction of thioredoxin significantly decreases its partial specific volume and adiabatic compressibility.

Por Kaminsky, S. M., Richards, F. M.
Publicado em 1992

Unnatural amino acid packing mutants of Escherichia coli thioredoxin produced by combined mutagenesis/chemical modification techniques.

Por Wynn, R., Richards, F. M.
Publicado em 1993

Optimal sequence selection in proteins of known structure by simulated evolution.

Por Hellinga, H W, Richards, F M
Publicado em 1994

Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin.

Por Richards, F M, Milner, J, Metcalfe, S
Publicado em 1992

Structure of the polyglutamic acid from Bacillus subtilis

Por Chibnall, A. C., Rees, M. W., Richards, F. M.
Publicado em 1958

Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem-5.

Por Lim, W. A., Fox, R. O., Richards, F. M.
Publicado em 1994

The crystal structure of a mutant protein with altered but improved hydrophobic core packing.

Por Lim, W A, Hodel, A, Sauer, R T, Richards, F M
Publicado em 1994

Increase in apparent compressibility of cytochrome c upon oxidation.

Por Eden, D, Matthew, J B, Rosa, J J, Richards, F M
Publicado em 1982

Interactions in nonnative and truncated forms of staphylococcal nuclease as indicated by mutational free energy changes.

Por Wynn, R., Anderson, C. L., Richards, F. M., Fox, R. O.
Publicado em 1995

Mobile unnatural amino acid side chains in the core of staphylococcal nuclease.

Por Wynn, R., Harkins, P. C., Richards, F. M., Fox, R. O.
Publicado em 1996

Methylene as a possible universal footprinting reagent that will include hydrophobic surface areas: overview and feasibility: properties of diazirine as a precursor.

Por Richards, F. M., Lamed, R., Wynn, R., Patel, D., Olack, G.
Publicado em 2000

Comparison of straight chain and cyclic unnatural amino acids embedded in the core of staphylococcal nuclease.

Por Wynn, R., Harkins, P. C., Richards, F. M., Fox, R. O.
Publicado em 1997

Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes.

Por Clifford, S. C., Czapla, K., Richards, F. M., O'Donoghue, D. J., Maher, E. R.
Publicado em 1998

An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.

Por Webster, A R, Richards, F M, MacRonald, F E, Moore, A T, Maher, E R
Publicado em 1998

Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Por Maher, E R, Webster, A R, Richards, F M, Green, J S, Crossey, P A, Payne, S J, Moore, A T
Publicado em 1996

Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.

Por Prowse, A H, Webster, A R, Richards, F M, Richard, S, Olschwang, S, Resche, F, Affara, N A, Maher, E R
Publicado em 1997

Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers.

Por Maher, E R, Bentley, E, Payne, S J, Latif, F, Richards, F M, Chiano, M, Hosoe, S, Yates, J R, Linehan, M, Barton, D E
Publicado em 1992

Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells

Por Lin, Y, Richards, F M, Krippendorff, B-F, Bramhall, J L, Harrington, J A, Bapiro, T E, Robertson, A, Zheleva, D, Jodrell, D I
Publicado em 2012